1. Home
  2. GRFS vs ACT Comparison

GRFS vs ACT Comparison

Compare GRFS & ACT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$8.93

Market Cap

6.5B

Sector

Health Care

ML Signal

HOLD

Logo Enact Holdings Inc.

ACT

Enact Holdings Inc.

HOLD

Current Price

$42.58

Market Cap

5.6B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRFS
ACT
Founded
1940
1981
Country
Spain
United States
Employees
23800
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Specialty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
6.5B
5.6B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
GRFS
ACT
Price
$8.93
$42.58
Analyst Decision
Hold
Hold
Analyst Count
2
3
Target Price
$10.15
$42.67
AVG Volume (30 Days)
446.1K
309.4K
Earning Date
01-01-0001
05-05-2026
Dividend Yield
1.54%
1.98%
EPS Growth
N/A
6.33
EPS
N/A
3.30
Revenue
N/A
$1,201,774,000.00
Revenue This Year
$5.47
$4.14
Revenue Next Year
$4.92
$2.41
P/E Ratio
$18.67
$12.83
Revenue Growth
N/A
4.17
52 Week Low
$6.19
$31.28
52 Week High
$11.14
$44.80

Technical Indicators

Market Signals
Indicator
GRFS
ACT
Relative Strength Index (RSI) 42.21 57.79
Support Level $8.66 $37.06
Resistance Level $9.11 $44.80
Average True Range (ATR) 0.29 1.04
MACD -0.05 -0.15
Stochastic Oscillator 42.28 49.76

Price Performance

Historical Comparison
GRFS
ACT

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

About ACT Enact Holdings Inc.

Enact Holdings Inc is a private mortgage insurance company serving the United States housing finance market. The principal mortgage insurance customers are originators of residential mortgage loans who determine which mortgage insurer or insurers will be used for the placement of mortgage insurance written on loans originated. The company is engaged in writing and assuming residential mortgage guaranty insurance.

Share on Social Networks: